Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

ConditionsCancer Head and Neck Cancer

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorM.D. Anderson Cancer Center

About this trial

The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Aged 18 or greater

Patient scheduled to undergo facial nerve transfer

Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

Nerve transfer techniques
Procedure/Surgery
Participants will undergo facial nerve reconstruction using nerve transfer techniques

Treatment groups

40 Participants

are divided into 2 treatment groups

Group A: ControlExperimental treatment 1 intervention

Group B: SurgeryExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

Safety and Adverse Events (AEs)

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Time frame

Through study completion; an average of 1 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

Source ClinicalTrials.gov

Apply now